Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 1
1965 1
1966 1
1967 2
1969 3
1970 1
1971 5
1972 8
1973 3
1974 2
1975 3
1976 3
1977 3
1978 2
1979 1
1980 6
1981 6
1982 5
1983 4
1984 8
1985 9
1986 6
1987 6
1988 7
1989 12
1990 9
1991 8
1992 14
1993 13
1994 14
1995 13
1996 13
1997 18
1998 19
1999 20
2000 23
2001 20
2002 20
2003 19
2004 31
2005 45
2006 38
2007 51
2008 48
2009 45
2010 74
2011 92
2012 97
2013 100
2014 106
2015 127
2016 128
2017 147
2018 124
2019 126
2020 133
2021 135
2022 107
2023 119
2024 121
2025 103
2026 69

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,181 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial.
Liu-Ambrose T, Falck RS, Dao E, Best JR, Davis JC, Bennett K, Hall PA, Hsiung GR, Middleton LE, Goldsmith CH, Graf P, Eng JJ. Liu-Ambrose T, et al. Among authors: bennett k. JAMA Netw Open. 2022 Oct 3;5(10):e2236510. doi: 10.1001/jamanetworkopen.2022.36510. JAMA Netw Open. 2022. PMID: 36227593 Free PMC article. Clinical Trial.
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Among authors: bennett k. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.
Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB. Brown AJH, et al. Among authors: bennett ka. Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001. Cell. 2021. PMID: 34822784 Free PMC article. Clinical Trial.
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Alexander SPH, Davenport AP, Kelly E, Gibb AJ, Mathie AA, Peach CJ, Veale EL, Armstrong JF, Faccenda E, Harding SD, Southan C, Davies JA, Abbracchio MP, Abraham GR, Agoulnik A, Alexander W, Al-Hosaini K, Bäck M, Baker JG, Barnes NM, Bathgate R, Beaulieu JM, Beck-Sickinger AG, Behrens M, Bennett KA, Bernstein KE, Bettler B, Birdsall NJM, Blaho VA, Bonaventure P, Boulay F, Bousquet C, Bräuner-Osborne H, Brown AJ, Burnstock G, Busnelli M, Caló G, Caruso V, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Christopoulos A, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Cox HM, Csaba Z, Dahlgren C, Dautzenberg FM, Dent G, Douglas SD, Dournaud P, Dubocovich ML, Eguchi S, Escher E, Filardo EJ, Fong T, Forsman HF, Fumagalli M, Gainetdinov RR, Garelja ML, de Gasparo M, Gbahou F, Gerard C, Gershengorn M, Glass M, Gloriam DE, Gobeil F, Goodfriend TL, Goudet C, Grätz L, Gregory KJ, Gruber C, Gundlach AL, Hamann J, Hanson J, Hartman DS, Hauger RL, Hay DL, Heinemann A, Heitman L, Herr DR, Hollenberg MD, Holliday ND, Holst B, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Insel PA, Jacobson KA, Jacobson LH, Jensen RT, Jockers R, Jonnalagadda D, Karnik S… See abstract for full author list ➔ Alexander SPH, et al. Among authors: bennett ka. Br J Pharmacol. 2025 Dec;182 Suppl 1(Suppl 1):S24-S151. doi: 10.1111/bph.70230. Br J Pharmacol. 2025. PMID: 41461581 Free PMC article. Review.
TMBIM5 is the Ca2+ /H+ antiporter of mammalian mitochondria.
Austin S, Mekis R, Mohammed SEM, Scalise M, Wang WA, Galluccio M, Pfeiffer C, Borovec T, Parapatics K, Vitko D, Dinhopl N, Demaurex N, Bennett KL, Indiveri C, Nowikovsky K. Austin S, et al. Among authors: bennett kl. EMBO Rep. 2022 Dec 6;23(12):e54978. doi: 10.15252/embr.202254978. Epub 2022 Nov 2. EMBO Rep. 2022. PMID: 36321428 Free PMC article.
Resazurin dye is an in vivo sensor of kidney tubular function.
Martinez SA, Karel IZ, Silvaroli JA, Ahmed E, Kim JY, Stayton A, Patel PS, Afjal MA, Horton T, Bohmer M, Vanichapol T, Sander V, Andrade GM, Allison CV, Mondal M, Thorson VC, Partey A, Nimkar K, Williams V, Quimby J, Ganesan L, Madhavan SM, Davidson AJ, Peterson BR, Adebiyi A, Rao R, Sweet DH, Singh P, Bennett KM, Zepeda-Orozco D, Mallipattu SK, Eisenmann ED, Sparreboom A, Rovin BH, Bajwa A, Pabla NS. Martinez SA, et al. Among authors: bennett km. Kidney Int. 2025 Mar;107(3):508-520. doi: 10.1016/j.kint.2024.12.008. Epub 2024 Dec 27. Kidney Int. 2025. PMID: 39733791 Free PMC article.
The patellar ligament: A comprehensive review.
Bennett K, Vincent T, Sakthi-Velavan S. Bennett K, et al. Clin Anat. 2022 Jan;35(1):52-64. doi: 10.1002/ca.23791. Epub 2021 Oct 5. Clin Anat. 2022. PMID: 34554600 Review.
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.
Nash PS, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Ndoutoumou A, Norrving B, Philip J, Sims H, Sprigg N, Vanniyasingam T, Freemantle N, Wheeler DC, Werring DJ; OPTIMAS Investigators. Nash PS, et al. Among authors: bennett k. Stroke. 2025 Aug;56(8):1970-1979. doi: 10.1161/STROKEAHA.125.051457. Epub 2025 May 22. Stroke. 2025. PMID: 40402086 Free article. Clinical Trial.
2,181 results